| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S18513 R78667 |
Zafeiri, 2022 | Gastroschisis | during pregnancy (anytime or not specified) excluded | retrospective cohort | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: maternal ITW/questionnaires during pregnancy |
0.99 [0.45;2.21] excluded (exposition period) |
10/24,099 23/107,143 | 33 | 24,099 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18499 R78644 |
Goodman, 2019 | Gastroschisis diagnosed by ultrasound (less than 24 weeks gestation) | during pregnancy (anytime or not specified) excluded | case control | unexposed (general population or NOS) | Adjustment: Yes Matched Paracetamol use: maternal ITW/questionnaires during pregnancy |
0.68 [0.25;1.94] excluded (exposition period) |
18/72 11/33 | 29 | 72 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18497 R78639 |
Given, 2017 | Gastroschisis (excluding diabetes and anti-epileptic medication exposed) | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: prescription or medical files | 1.69 [1.00;2.85] | 15/1,038 -/- | - | 1,038 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18498 R78669 |
Robledo-Aceves, 2015 | Nonsyndromic gastroschisis | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: not specified | 0.70 [0.30;1.40] | 19/61 71/209 | 90 | 61 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18501 R79041 |
Feldkamp, 2010 | Gastroschisis | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: maternal ITW/questionnaires after pregnancy | 1.03 [0.83;1.28] | 212/2,168 255/2,442 | 467 | 2,168 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18505 R78756 |
Rebordosa a, 2008 | Gastroschisis | 1st trimester | prospective cohort | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: maternal ITW/questionnaires during pregnancy | 0.91 [0.55;4.09] | 3/26,424 9/61,718 | 12 | 26,424 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18503 R78915 |
Werler, 2002 | Gastroschisis (newborn infants with intestines protruding through the wall of the abdomen lateral to, but not involving, the umbilicus) | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: Yes Matched Paracetamol use: maternal ITW/questionnaires after pregnancy | 1.50 [1.00;2.10] | 90/412 116/592 | 206 | 412 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18504 R78670 |
Torfs, 1996 | Gastroschisis | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: No Matched Paracetamol use: maternal ITW/questionnaires after pregnancy | 1.00 [0.59;1.69] | 28/84 82/246 | 110 | 84 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18502 R78911 |
Werler, 1992 | Gastroschisis | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: maternal ITW/questionnaires after pregnancy | 1.70 [1.00;2.90] | 51/1,126 25/1,092 | 76 | 1,126 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 7 studies | 1.21 [0.97;1.51] | 961 | 31,313 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asymetry test p-value = 0.7761 (by Egger's regression)
slope=0.0963 (0.2327); intercept=0.3355 (1.1179); t=0.3002; p=0.7761
excluded